-
Development of a novel intranasal oligonucleotide delivery approach for Huntington disease
Huntington disease (HD) is a progressive brain disorder affecting movement, mood, and cognitive skills, caused by inheriting…
View details2019Competition
-
Development of a novel prognostic model in Follicular Lymphoma
Lymphoid cancers are the fourth most common cancers in Canada. The incidence of follicular lymphoma (FL), a…
View details2008Competition
-
Development of a patient-centred decision aid for rehabilitation in the advanced cancer setting
Advanced cancer and its treatment can lead to physical function declines and disability. Physical function is the…
View details2023Competition
-
Development of a pipeline for the analysis of flow cytometry data
Flow cytometry (FCM) is a method of sorting and measuring types of cells by fluorescent labelling of…
View details2008Competition
-
Development of Clinical Standards of Care for Huntington disease Intermediate Allele Predictive Test Results
Predictive testing for Huntington disease (HD) has been available since 1986. This genetic test has the ability…
View details2009Competition
-
Development of Fluorinated Carbohydrates for use as Positron Emission Tomography Imaging Agents and Pharmacological Chaperones in the Treatment of Lysosomal storage diseases
Lysosomal Storage Diseases (LSD) are a rare group of more than 40 disorders, including conditions such as…
View details2007Competition
-
Development of improved substrates for live cell imaging to aid in discovering new glucocerebrosidase therapeutic agents
Parkinson’s disease (PD) is a neurodegenerative disorder that affects millions of people worldwide, with no standard treatment…
View details2017Competition
-
Development of mutation-robust vaccines and antibodies, and their implications for the evolution of SARS-CoV-2
COVID-19 has caused over 774 million cases and 7.02 million deaths worldwide as of February, 2024. The…
View details2024Competition
-
Development of natural killer (NK) cells from a novel progenitor
Natural Killer (NK) cells are immune cells with an important role in the first line of defense…
View details2008Competition
-
Development of Novel Alpha-amanitin Analogs for Targeted Cancer Chemotherapy
New toxins for incorporation into treatments known as antibody-drug conjugates are urgently needed to ensure therapeutic action.…
View details2020Competition
-
Development of novel indolmycin derivatives for the treatment of MRSA
Since the discovery of antibiotics over 80 years ago, bacterial infections have been relatively straightforward to treat.…
View details2015Competition
-
Development of potential therapeutics for influenza via sialidase inactivators
Influenza is a severe infection of the upper respiratory tract that occurs each year, affecting approximately 20…
View details2007Competition
Connect with us
We love to chat about our programs, activities and partnership opportunities. Don’t hesitate to reach out to us.
Contact us